Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;100(6):1401-1406.
doi: 10.4269/ajtmh.18-0834.

Enhanced Mycobacterial Antigen-Induced Pro-Inflammatory Cytokine Production in Lymph Node Tuberculosis

Affiliations

Enhanced Mycobacterial Antigen-Induced Pro-Inflammatory Cytokine Production in Lymph Node Tuberculosis

Gokul Raj Kathamuthu et al. Am J Trop Med Hyg. 2019 Jun.

Abstract

Lymph node tuberculosis (LNTB) is characterized by the enhanced baseline and antigen-specific production of type 1/17 cytokines and reduced baseline and antigen-specific production of interleukin (IL)-1β and IL-18 at the site of infection when compared with peripheral blood. However, the cytokine profile in the lymph nodes (LNs) of Mycobacterium tuberculosis culture-positive LNTB (LNTB+) and negative LNTB (LNTB-) has not been examined. To address this, we have examined the baseline and mycobacterial antigen-stimulated cytokine levels of type 1 (interferon gamma [IFNγ], tumor necrosis factor alpha [TNFα], IL-2), type 2 (IL-4, IL-5, and IL-13), type 17 (IL-17A, IL-17F, and IL-22), pro-inflammatory (IL-1α, IL-1β, IL-18, and granulocyte macrophage colony-stimulating factor [GM-CSF]), and regulatory cytokines (IL-10, transforming growth factor beta [TGF-β]) cytokines in the LN culture supernatants of LNTB+ and LNTB- individuals. We have observed significantly enhanced baseline levels of IL-13 and IL-10 and significantly reduced baseline levels of IL-4 and GM-CSF in LNTB+ individuals compared with LNTB- individuals. By contrast, we have observed significantly enhanced levels of type 1 (IFNγ, TNFα, and IL-2), type 17 (IL-17F and IL-22), and pro-inflammatory (IL-1α and GM-CSF) cytokines and significantly reduced levels of TGFβ in response to purified protein derivative, early secreted antigen-6, and culture filtrate protein-10 antigens in LNTB+ compared with LNTB- individuals. On phorbol 12-myristate 13-acetate/ionomycin stimulation, no significant difference was observed for any of the cytokines examined. Thus, our study revealed several interesting differences in the cytokine profiles of mycobacterial antigen-stimulated LN cultures in LNTB+ and LNTB- individuals. Therefore, we suggest the presence of mycobacteria plays a significant role in driving the cytokine response at the site of infection in LNTB.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Baseline, purified protein derivative (PPD), and Phorbol 12-myristate 13-acetate/ionomycin (P/I) stimulated cytokine production in positive lymph node tuberculosis (LNTB+) and negative lymph node tuberculosis (LNTB−) individuals. The (A) unstimulated, (B) PPD and, (C) P/I stimulated culture supernatant levels of type 1 (interferon gamma [IFNγ], tumor necrosis factor alpha [TNFα], and interleukin [IL]-2), type 17 (IL-17, IL-17F, and IL-22), type 2 (IL-4, IL-5, and IL-13), regulatory (IL-10 and TGFβ), IL-1 family (IL-1α and IL-1β), and other pro-inflammatory (IL-18 and GM-CSF) cytokines were measured in lymph node cell suspensions of LNTB+ and LNTB− individuals. Each circle represents a single individual, and the bars represent the geometric mean values. Net cytokine levels were calculated by subtracting the baseline levels from the antigen-induced levels for each individual. P values were calculated using the Mann–Whitney U test.

Similar articles

Cited by

References

    1. Sharma SK, Mohan A, 2004. Extrapulmonary tuberculosis. Ind J Med Res 120: 316–353. - PubMed
    1. Korea Centers for Disease Control and Prevention , 2014. Annual Report on the Notified Tuberculosis in Korea. Cheongwon, Korea: Korea Centers for Disease Control and Prevention, 2013.
    1. Gothi D, Jaswal A, Spalgais S, 2016. Lymph node tuberculosis. EC Pulmonol Respir Med 2.5: 194–211.
    1. Handa U, Mundi I, Mohan S, 2012. Nodal tuberculosis revisited: a review. J Infect Dev Ctries 6: 6–12. - PubMed
    1. Knox J, Lane G, Wong JSJ, Trevan PG, Karunajeewa H, 2012. Diagnosis of tuberculous lymphadenitis using fine needle aspiration biopsy. Intern Med J 42: 1029–1036. - PubMed

Publication types